Evicenter
MarkdownMedical informationP&T meetings
Ficerafusp alfa (BCA101)

First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab

Last updated
135 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Incidence of HPV-negative head and neck squamous cell carcinoma

15 evidence topics · 13 sources

HPV-negative share of U.S. oropharyngeal squamous cell carcinoma
Oropharynx, United States, 2012 to 2016Quoted value
Average annual reported cases“19,000”View highlighted excerpt for this quote
Attributable to 9vHPV-targeted types, number (%)“12,600 (66)”View highlighted excerpt for this quote
Attributable to other HPV types, number (%)“900 (5)”View highlighted excerpt for this quote
HPV-negative, number (%)“5,500 (29)”View highlighted excerpt for this quote